# OnCo record nct06782555 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06782555/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06782555", "NCT06782555" ;
  schema:name "A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab"@en ;
  schema:description "A phase 1/2 trial of Zalifrelimab and Balstilimab in prostate cancer, head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma, run by ImmunoGenesis, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06782555/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06782555> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2025-01-08" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:drugs <https://onco.cc/drugs/zalifrelimab/>, <https://onco.cc/drugs/balstilimab/>, <https://onco.cc/drugs/evofosfamide/> ;
  onco:companies <https://onco.cc/companies/agenus/> .